PRIMARY CARBOXAMIDES AS BTK INHIBITORS
The invention provides compounds of Formula (I)pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions.
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | FRANK, Kristine E BONAFOUX, Dominique OSUMA, Augustine HUNTLEY, Raymond VASUDEVAN, Anil DAVIS, Heather M HEROLD, J. Martin HOEMANN, Michael Z VAN CAMP, Jennifer WILSON, Noel S FRIEDMAN, Michael M SHEPPARD, George VAN EPPS, Stacy A SOMAL, Gagandeep K XU, Xiangdong WALLACE, Grier A WANG, Lu WANG, Zhi |
| description | The invention provides compounds of Formula (I)pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_ZA201509012B</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ZA201509012B</sourcerecordid><originalsourceid>FETCH-epo_espacenet_ZA201509012B3</originalsourceid><addsrcrecordid>eNrjZFALCPL0dQyKVHB2DHLyj3D09XRxDVZwDFZwCvFW8PTz8HTyDPEPCuZhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfFRjkYGhqYGlgaGRk7GxKgBAMb9I5E</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PRIMARY CARBOXAMIDES AS BTK INHIBITORS</title><source>esp@cenet</source><creator>FRANK, Kristine E ; BONAFOUX, Dominique ; OSUMA, Augustine ; HUNTLEY, Raymond ; VASUDEVAN, Anil ; DAVIS, Heather M ; HEROLD, J. Martin ; HOEMANN, Michael Z ; VAN CAMP, Jennifer ; WILSON, Noel S ; FRIEDMAN, Michael M ; SHEPPARD, George ; VAN EPPS, Stacy A ; SOMAL, Gagandeep K ; XU, Xiangdong ; WALLACE, Grier A ; WANG, Lu ; WANG, Zhi</creator><creatorcontrib>FRANK, Kristine E ; BONAFOUX, Dominique ; OSUMA, Augustine ; HUNTLEY, Raymond ; VASUDEVAN, Anil ; DAVIS, Heather M ; HEROLD, J. Martin ; HOEMANN, Michael Z ; VAN CAMP, Jennifer ; WILSON, Noel S ; FRIEDMAN, Michael M ; SHEPPARD, George ; VAN EPPS, Stacy A ; SOMAL, Gagandeep K ; XU, Xiangdong ; WALLACE, Grier A ; WANG, Lu ; WANG, Zhi</creatorcontrib><description>The invention provides compounds of Formula (I)pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions.</description><language>eng</language><creationdate>2020</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200527&DB=EPODOC&CC=ZA&NR=201509012B$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200527&DB=EPODOC&CC=ZA&NR=201509012B$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>FRANK, Kristine E</creatorcontrib><creatorcontrib>BONAFOUX, Dominique</creatorcontrib><creatorcontrib>OSUMA, Augustine</creatorcontrib><creatorcontrib>HUNTLEY, Raymond</creatorcontrib><creatorcontrib>VASUDEVAN, Anil</creatorcontrib><creatorcontrib>DAVIS, Heather M</creatorcontrib><creatorcontrib>HEROLD, J. Martin</creatorcontrib><creatorcontrib>HOEMANN, Michael Z</creatorcontrib><creatorcontrib>VAN CAMP, Jennifer</creatorcontrib><creatorcontrib>WILSON, Noel S</creatorcontrib><creatorcontrib>FRIEDMAN, Michael M</creatorcontrib><creatorcontrib>SHEPPARD, George</creatorcontrib><creatorcontrib>VAN EPPS, Stacy A</creatorcontrib><creatorcontrib>SOMAL, Gagandeep K</creatorcontrib><creatorcontrib>XU, Xiangdong</creatorcontrib><creatorcontrib>WALLACE, Grier A</creatorcontrib><creatorcontrib>WANG, Lu</creatorcontrib><creatorcontrib>WANG, Zhi</creatorcontrib><title>PRIMARY CARBOXAMIDES AS BTK INHIBITORS</title><description>The invention provides compounds of Formula (I)pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2020</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFALCPL0dQyKVHB2DHLyj3D09XRxDVZwDFZwCvFW8PTz8HTyDPEPCuZhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfFRjkYGhqYGlgaGRk7GxKgBAMb9I5E</recordid><startdate>20200527</startdate><enddate>20200527</enddate><creator>FRANK, Kristine E</creator><creator>BONAFOUX, Dominique</creator><creator>OSUMA, Augustine</creator><creator>HUNTLEY, Raymond</creator><creator>VASUDEVAN, Anil</creator><creator>DAVIS, Heather M</creator><creator>HEROLD, J. Martin</creator><creator>HOEMANN, Michael Z</creator><creator>VAN CAMP, Jennifer</creator><creator>WILSON, Noel S</creator><creator>FRIEDMAN, Michael M</creator><creator>SHEPPARD, George</creator><creator>VAN EPPS, Stacy A</creator><creator>SOMAL, Gagandeep K</creator><creator>XU, Xiangdong</creator><creator>WALLACE, Grier A</creator><creator>WANG, Lu</creator><creator>WANG, Zhi</creator><scope>EVB</scope></search><sort><creationdate>20200527</creationdate><title>PRIMARY CARBOXAMIDES AS BTK INHIBITORS</title><author>FRANK, Kristine E ; BONAFOUX, Dominique ; OSUMA, Augustine ; HUNTLEY, Raymond ; VASUDEVAN, Anil ; DAVIS, Heather M ; HEROLD, J. Martin ; HOEMANN, Michael Z ; VAN CAMP, Jennifer ; WILSON, Noel S ; FRIEDMAN, Michael M ; SHEPPARD, George ; VAN EPPS, Stacy A ; SOMAL, Gagandeep K ; XU, Xiangdong ; WALLACE, Grier A ; WANG, Lu ; WANG, Zhi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_ZA201509012B3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2020</creationdate><toplevel>online_resources</toplevel><creatorcontrib>FRANK, Kristine E</creatorcontrib><creatorcontrib>BONAFOUX, Dominique</creatorcontrib><creatorcontrib>OSUMA, Augustine</creatorcontrib><creatorcontrib>HUNTLEY, Raymond</creatorcontrib><creatorcontrib>VASUDEVAN, Anil</creatorcontrib><creatorcontrib>DAVIS, Heather M</creatorcontrib><creatorcontrib>HEROLD, J. Martin</creatorcontrib><creatorcontrib>HOEMANN, Michael Z</creatorcontrib><creatorcontrib>VAN CAMP, Jennifer</creatorcontrib><creatorcontrib>WILSON, Noel S</creatorcontrib><creatorcontrib>FRIEDMAN, Michael M</creatorcontrib><creatorcontrib>SHEPPARD, George</creatorcontrib><creatorcontrib>VAN EPPS, Stacy A</creatorcontrib><creatorcontrib>SOMAL, Gagandeep K</creatorcontrib><creatorcontrib>XU, Xiangdong</creatorcontrib><creatorcontrib>WALLACE, Grier A</creatorcontrib><creatorcontrib>WANG, Lu</creatorcontrib><creatorcontrib>WANG, Zhi</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>FRANK, Kristine E</au><au>BONAFOUX, Dominique</au><au>OSUMA, Augustine</au><au>HUNTLEY, Raymond</au><au>VASUDEVAN, Anil</au><au>DAVIS, Heather M</au><au>HEROLD, J. Martin</au><au>HOEMANN, Michael Z</au><au>VAN CAMP, Jennifer</au><au>WILSON, Noel S</au><au>FRIEDMAN, Michael M</au><au>SHEPPARD, George</au><au>VAN EPPS, Stacy A</au><au>SOMAL, Gagandeep K</au><au>XU, Xiangdong</au><au>WALLACE, Grier A</au><au>WANG, Lu</au><au>WANG, Zhi</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PRIMARY CARBOXAMIDES AS BTK INHIBITORS</title><date>2020-05-27</date><risdate>2020</risdate><abstract>The invention provides compounds of Formula (I)pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_ZA201509012B |
| source | esp@cenet |
| title | PRIMARY CARBOXAMIDES AS BTK INHIBITORS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T07%3A21%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=FRANK,%20Kristine%20E&rft.date=2020-05-27&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EZA201509012B%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |